申请人:Kandula Mahesh
公开号:US20150057347A1
公开(公告)日:2015-02-26
The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I or formula II; and methods for treating or preventing inflammation and lipid disorders may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of hypertriglyceridemia, steatohepatitis, cystinosis and inflammatory diseases.
该发明涉及公式I和公式II的化合物或其药用可接受的盐,以及其多晶型、溶剂合物、对映体、立体异构体和水合物。包括有效量的公式I或公式II化合物的药物组合物;以及用于治疗或预防炎症和脂质紊乱的方法可以制成口服、颊内、直肠、局部、经皮、经粘膜、静脉、肠道给药、糖浆或注射剂。这种组合物可用于治疗高三酸甘油酯血症、脂肪肝、半胱氨酸症和炎症性疾病。